Baltimore, Maryland
Phase 1 cancer trials in Baltimore, MD
50 Phase 1 cancer studies are recruiting participants at sites in Baltimore as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Baltimore at a glance
- 50 studies are recruiting at a site in Baltimore.
- By phase: Early Phase 1 (3), Phase 1 (25), Phase 1/2 (22).
- By sponsor: industry (35), university, hospital or other (13), government (2).
- By research area: Lung Cancer (20), Lymphoma (10), Prostate Cancer (9), Breast Cancer (7), Pancreatic Cancer (3), Melanoma (1).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Baltimore
Basic details from each study's public record (the 30 most recently updated of 50). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- Sidney Kimmel Comprehensive Cancer Center
- Registry record
- NCT06638307 · updated
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT05123482 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Baltimore, MD on ClinicalTrials.gov.
Lung cancer studies recruiting in Baltimore
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Johns Hopkins University/Sidney Kimmel Cancer Center · University of Maryland/Greenebaum Cancer Center
- Registry record
- NCT06287775 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Johns Hopkins University
- Registry record
- NCT07020221 · updated
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Synthekine
- Study site
- University of Maryland
- Registry record
- NCT05098132 · updated
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT06996782 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #14
- Registry record
- NCT05176483 · updated
DK222 Study at Hopkins
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study site
- Johns Hopkins Hospital
- Registry record
- NCT07140315 · updated
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Johns Hopkins
- Registry record
- NCT07349537 · updated
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center
- Registry record
- NCT06343402 · updated
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study site
- Johns Hopkins University
- Registry record
- NCT05950139 · updated
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
- Registry record
- NCT05142189 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins
- Registry record
- NCT06131840 · updated
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
- Registry record
- NCT06179160 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Baltimore, MD on ClinicalTrials.gov.
Prostate cancer studies recruiting in Baltimore
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
- Phase 1
- Ages 40 to 75
- Male participants
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins Hospital
- Registry record
- NCT07271017 · updated
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Phase 1
- Ages 18 to 100
- Male participants
- Sponsor
- Janux Therapeutics
- Study site
- University of Maryland Greenebaum Comprehensive Cancer Center
- Registry record
- NCT05519449 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center
- Registry record
- NCT05919264 · updated
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Acerand Therapeutics (Hong Kong) Limited
- Study site
- University of Maryland, Greenebaum Comprehensive Cancer Center
- Registry record
- NCT06801236 · updated
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Pathos AI, Inc.
- Study site
- Johns Hopkins Hospital
- Registry record
- NCT06785636 · updated
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
- Phase 1
- Ages 21 and older
- Male participants
- Sponsor
- Alessa Therapeutics Inc.
- Study site
- Johns Hopkins University School of Medicine
- Registry record
- NCT06257693 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Baltimore, MD on ClinicalTrials.gov.
Melanoma studies recruiting in Baltimore
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Johns Hopkins University/Sidney Kimmel Cancer Center
- Registry record
- NCT05896839 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Baltimore, MD on ClinicalTrials.gov.
Lymphoma studies recruiting in Baltimore
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study sites
- Johns Hopkins University/Sidney Kimmel Cancer Center · Sinai Hospital of Baltimore
- Registry record
- NCT04726241 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- John Hopkins University
- Registry record
- NCT05384626 · updated
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Phase 1/2
- From 6 months, up to 30 years
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Johns Hopkins University
- Registry record
- NCT05533775 · updated
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AIDS Malignancy Consortium
- Study site
- Johns Hopkins University/Sidney Kimmel Cancer Center
- Registry record
- NCT04139304 · updated
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study site
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Registry record
- NCT06398457 · updated
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Phase 1/2
- From 12 months, up to 21 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- Johns Hopkins University/Sidney Kimmel Cancer Center
- Registry record
- NCT04870944 · updated
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Imugene Limited
- Study site
- University of Maryland
- Registry record
- NCT03666000 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Baltimore, MD on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Baltimore
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins
- Registry record
- NCT06445062 · updated
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study site
- Sidney Kimmel Comprehensive Cancer Center
- Registry record
- NCT06411691 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Baltimore, MD on ClinicalTrials.gov.
Ask about studies near Baltimore
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections